Watch Dr. Ferrara’s Journal of Clinical Investigation Interview discussing GVHD

https://www.youtube.com/watch?v=y3AZnepkQ0Y&feature=youtu.be

 

Read about the First, Predictive Acute Graft Versus Host Disease (aGVHD) Algorithms with Clinical Cutoffs to Predict Risk of Graft vs. Host Disease & Non-Relapse Mortality for HCT Patients

https://www.viracor-eurofins.com/landing-page-collection/agvhd/

 

Read about a new $10 million grant given to the Tisch Cancer Institute to study GVHD

http://inside.mountsinai.org/blog/the-tisch-cancer-institute-receives-a-10-million-grant-to-study-acute-graft-versus-host-disease/

 

Read a report of how biomarkers can be used to predict GVHD prior to any symptoms developing

https://www.sciencedaily.com/releases/2017/02/170209133448.htm

 

Watch Dr. Ferrara discuss GVHD

http://www.healio.com/hematology-oncology/leukemia/news/online/%7B46338450-a2d2-41b7-a866-2e99b1d53035%7D/video-james-l-m-ferrara-md-dsc-reviews-long-standing-problem-of-gvhd-after-allogeneic-hsct

 

Watch Dr. Ferrara present the latest research on GVHD at the Mount Sinai medical grand round

https://www.youtube.com/watch?v=1az-VSkvUPo

 

Watch Dr. Ferrara’s discussion at Arise America – Fighting Blood Cancers

http://youtu.be/4iB-YIRKRCc

 

Read about Biomarkers predicted severity of GVHD after allogeneic HSCT Hematology Oncology

http://www.healio.com/hematology-oncology/bone-marrow-transplantation/news/in-the-journals/%7B47a7d268-8c51-46b0-b1b5-16ff8d023029%7D/biomarkers-predicted-severity-of-gvhd-after-allogeneic-hsct

 

Read Inside Mount Sinai – A New Era for Bone Marrow Transplantation

http://www.mountsinai.org/static_files/MSMC/Files/Inside%20Mount%20Sinai/2015/020915-inside.pdf